Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on July 30, 2025
Global Mining Market Size Poised to Cross $350 Billion in Revenue By 2037 Despite Geopolitical Uncertainties
GlobeNewswire
·
July 30, 2025
PALM BEACH, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The demand for gold is rising every year. Besides being a safe-haven asset, the novel metal is also a crucial part is manufacturing electronics, raising the surge for gold …
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin
GlobeNewswire
·
July 30, 2025
– New patent enhances market position in Europe HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard- …
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
GlobeNewswire
·
July 30, 2025
MALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, …
EXL and Genesys collaborate to transform customer experiences with AI-driven insights and intelligent orchestration
GlobeNewswire
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- EXL (NASDAQ: EXLS), a global data and AI company, and Genesys®, a global cloud leader in AI-powered experience orchestration, announced a collaboration to transform customer engagement and business operations …
Aterian Sets Date for Second Quarter 2025 Earnings Announcement & Investor Conference Call
GlobeNewswire
·
July 30, 2025
SUMMIT, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced that it will issue its financial results for the second quarter ended June 30, 2025 on Wednesday, August 13, 2025 after the close of …
Regula and Indicio Partner to Transform Identity Verification With Verifiable Credentials
GlobeNewswire
·
July 30, 2025
RESTON, Va., July 30, 2025 (GLOBE NEWSWIRE) -- Regula, a global developer of identity verification (IDV) solutions and forensic devices, enters a strategic technology partnership with Indicio, a market leader in Verifiable Credential technology and …
Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing
GlobeNewswire
·
July 30, 2025
AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis …
$9.8M Contract Propels Intuitive Machines’ Orbital Transfer Vehicle Toward Flight Readiness
GlobeNewswire
·
July 30, 2025
HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology and infrastructure services company, has secured a $9.8 million Phase Two government contract to advance …
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed
GlobeNewswire
·
July 30, 2025
Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data from Cohort 1 and Initial Data from Cohort 2 Expected in Fourth Quarter of 2025 First Patient Dosed in 6E13 …
North Pole Security Raises $4M to Bring Scalable, Proactive Endpoint Protection to the Enterprise
GlobeNewswire
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- North Pole Security today announced it has raised $4 million in seed funding to deliver the first scalable, enterprise-grade endpoint protection platform for macOS, designed for proactive malware prevention. Led …
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
GlobeNewswire
·
July 30, 2025
NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March …
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
GlobeNewswire
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secured a major contract …
Brag House and Gators Athletics Score Big Again with Successful "Brag Gators Gauntlet: Preseason Edition"
GlobeNewswire
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (“Brag House”) (NASDAQ: TBH), the Gen Z engagement platform at the intersection of gaming, college sports, and digital media, today announced the successful conclusion of the "Brag …
SAIC Announces Alliance with Google Public Sector to Drive “AI at the Edge” with Google Distributed Cloud
GlobeNewswire
·
July 30, 2025
RESTON, Va., July 30, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) today announced an “AI at the Edge” strategic alliance with Google Public Sector, leveraging the power of Google Distributed Cloud. This multi-year …
NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025
GlobeNewswire
·
July 30, 2025
-- Pre-specified analysis shows obicetrapib significantly reduced absolute levels of plasma p-tau217, a key biomarker of Alzheimer’s disease pathology, in both the full analysis set (p=0.0019) and in ApoE4 carriers (p=0.0215), supporting CETP inhibition as …
Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
GlobeNewswire
·
July 30, 2025
Vancouver, Canada, July 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
happn unveils AI-powered tool to redefine date planning
GlobeNewswire
·
July 30, 2025
PARIS, July 30, 2025 (GLOBE NEWSWIRE) -- Real-life dating app happn, has launched Perfect Date — a world-first generative AI feature powered by large language models (LLMs). It helps users move from chatting to meeting-up through tailored location …
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
GlobeNewswire
·
July 30, 2025
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central …
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
July 30, 2025
NEEDHAM, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
GlobeNewswire
·
July 30, 2025
Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its …